Literature DB >> 27609271

Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis.

Georgios Efthymiou1, Efthymios Dardiotis2, Christos Liaskos3, Emmanouela Marou3, Vana Tsimourtou2, Thomas Scheper4, Wolfgang Meyer4, Alexandros Daponte5, Lazaros I Sakkas6, Georgios Hadjigeorgiou2, Dimitrios P Bogdanos7.   

Abstract

In view of published data suggesting that Helicobacter pylori (Hp) is a trigger of multiple sclerosis (MS), we assessed anti-heat shock protein 60 (hsp60)Hp antibody reactivity in 129 MS patients and 48 demograpically-matched healthy controls (HCs). Anti-Hp antibodies by ELISA were more elevated in MS than HCs but did not differ between different MS phenotypes. All anti-Hp-positive MS sera, irrespectively of their clinical phenotype, were anti-anti-hsp60 positive. Anti-hsp60 Hp seropositivity correlated with age at disease onset. In conclusion, anti-hsp60 Hp antibodies are present in all anti-Hp positive MS patients, and their relevance to disease pathogenesis is questionable.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Autoimmunity; Heat shock protein; Molecular mimicry

Mesh:

Substances:

Year:  2016        PMID: 27609271     DOI: 10.1016/j.jneuroim.2016.06.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

2.  Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis.

Authors:  Georgios Efthymiou; Christos Liaskos; Theodora Simopoulou; Emmanouela Marou; Eleni Patrikiou; Thomas Scheper; Wolfgang Meyer; Dimitrios Daoussis; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

3.  Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.

Authors:  Emmanouela Marou; Christos Liaskos; Theodora Simopoulou; Georgios Efthymiou; Efthymios Dardiotis; Christina Katsiari; Thomas Scheper; Wolfgang Meyer; Georgios Hadjigeorgiou; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2017-01-26       Impact factor: 2.980

4.  Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis.

Authors:  Georgios Efthymiou; Efthymios Dardiotis; Christos Liaskos; Emmanouela Marou; Vana Tsimourtou; Eirini I Rigopoulou; Thomas Scheper; Alexandros Daponte; Wolfgang Meyer; Lazaros I Sakkas; Georgios Hadjigeorgiou; Dimitrios P Bogdanos
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

5.  Gene variants of adhesion molecules act as modifiers of disease severity in MS.

Authors:  Efthimios Dardiotis; Elena Panayiotou; Antonios Provatas; Kyproula Christodoulou; Andreas Hadjisavvas; Athos Antoniades; Athanasios Lourbopoulos; Marios Pantzaris; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Theodoros Kyriakides
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-04-24

6.  Relevance of Helicobacter pylori infection in Egyptian multiple sclerosis patients.

Authors:  Steven Emil Gerges; Taha Kamel Alosh; Salma Hamed Khalil; Mona Mokhtar Waheed El Din
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.